R and D
CENTENNIAL, Colo., March 18, 2010—Cell>Point announced today that it was awarded…
CENTENNIAL, Colo., November 23, 2011
CENTENNIAL, Colo., June 6, 2011—Cell>Point announced today that it will present Phase 2 clinical trial results for its cancer molecular imaging agent, 99mTc-EC-G
April 18, 2012
Corporate Email Policy: Cell>Point does not retain emails after 7 days
Copyright@2017 Cell>Point, L.L.C.